Skip to main content

Table 2 The risk factors for the 30-day mortality in FluA-CAP patients

From: The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Variable

OR (95% CI)

p-value

Cardiovascular disease

3.189 (1.300–7.892)

< 0.001

Smoking history

3.294 (1.151–9.429)

< 0.001

Lymphocytes < 0.8 × 109/L

4.080 (1.321–12.596)

< 0.001

BUN > 7 mmol/L

2.158 (1.084–4.690)

< 0.001

pO2/FiO2 ≤ 250 mmHg

4.344 (2.050–9.203)

< 0.001

Early NAI therapy

0.415 (0.195–0.858)

0.001

  1. OR Odd ratio, CI Confidence interval